Tethys Bioscience, Inc.
5858 Horton Street
Suite 550
Emeryville
California
94608
United States
Tel: 510-903-3410
Fax: 510-428-0519
Website: http://www.tethysbio.com/
Email: info@tethysbio.com
24 articles about Tethys Bioscience, Inc.
-
Tethys Bioscience, Inc. Release: PreDx® Test Now Available With Finger Stick Collection Method
5/29/2013
-
Congresswoman Barbara Lee Visits Tethys Bioscience, Inc.
1/23/2013
-
Tethys Bioscience, Inc. and Lose it! Announce a Strategic Partnership to Support Diabetes Prevention
7/3/2012
-
Tethys Bioscience, Inc. and ACAP Health Consulting Partner to Help Employers Prevent Diabetes
12/7/2011
-
Tethys Bioscience, Inc. is Granted New York State Laboratory Permit for PreDx(R) Diabetes Risk Score
10/10/2011
-
Tethys Bioscience, Inc. Selected as 2012 Technology Pioneer by the World Economic Forum for Its Innovation in Diagnostics
9/1/2011
-
Tethys Bioscience, Inc. PreDx(R) Diabetes Risk Score Shows Superior Accuracy in Assessing Type 2 Diabetes Risk Versus Metabolic Syndrome
8/1/2011
-
Tethys Bioscience, Inc. PreDx(R) Diabetes Risk Score (DRS) Shown to Improve the Cost-effectiveness of Diabetes Prevention
7/11/2011
-
Structure House Presents Data Correlating Weight Loss, Reduction of Diabetes Risk Factors and Lowering of Tethys Bioscience, Inc.' PreDx(R) Diabetes Risk Score
6/27/2011
-
Data Show that a Decrease in Tethys Bioscience, Inc.' PreDx(R) Diabetes Risk Score (DRS) is Correlated with Lowered Risk of Diabetes
6/27/2011
-
Tethys Bioscience, Inc. Announces Data Presentations on PreDx(R) DRS at 2011 American Diabetes Association 71st Scientific Sessions
6/21/2011
-
Data Showing Use of Tethys Bioscience, Inc.’s PreDx(R) Diabetes Risk Score Improves Medical Management and Outcomes in Patients at High Risk for Type 2 Diabetes Presented at International Meeting
4/7/2011
-
Tethys Bioscience, Inc. and Duke Clinical Research Institute Establish PREVAIL Initiative to Improve Care and Reduce Incidence of Type 2 Diabetes
3/30/2011
-
Tethys Bioscience, Inc. and the United States Air Force Collaborate on a Clinical Trial to Assess Motivational Impact of the PreDx(R) Diabetes Risk Score on Positive Behavioral Change
3/23/2011
-
Tethys Bioscience, Inc. Seeks to Double Sales of Test, Prove Value of Preventing Diabetes
3/8/2011
-
Tethys Bioscience, Inc. Selects RemedyMD Enterprise Registry Solutions to Further Expand Adoption of PreDx(TM) Diabetes Risk Score (DRS) Offering
2/2/2011
-
Cardiometabolic Diagnostics Company, Tethys Bioscience, Inc. Raises $33 Million
7/23/2010
-
Tethys Bioscience, Inc. (JOBS) Raises $25 Million in Series D Financing
11/9/2009
-
Tethys Bioscience, Inc. Announces Personnel Additions and Promotions
8/31/2009
-
Peer-Reviewed Publications Demonstrate Tethys Bioscience, Inc.'s Ability to Identify Those at Highest Risk of Developing Type 2 Diabetes Within Five Years
7/15/2009